TABLE 1.
Plasmid, strain, or oligonucleotide | Relevant construction, genotype, or sequence (5′-3′) | Source or referenceb |
---|---|---|
Plasmids | ||
pBluescript II KS(+) | Multipurpose cloning/in vitro transcription phagemid vector, bla | Stratagene |
pMAD | Plasmid used for allelic replacement in Gram-positive bacteria, bla, erm | 2 |
pLitmus29 | Multipurpose cloning/in vitro transcription phagemid vector, bla | New England Biolabs |
pMS38 | pLitmus29 derivative used as a source of chloramphenicol resistance cassette, bla, cat | 35 |
pJL3 | pLitmus29 derivative used as a source of kanamycin resistance cassette, bla, kan | This work |
pMJ1 | pBluescript II KS(+) derivative harboring the msmX coding region, bla | This work |
pMJ2 | pMJ1 derivative used for the creation of msmX-null mutations, bla, cat | This work |
pMJ6 | pMAD derivative used for the creation of araN in-frame deletion mutants, bla, erm | This work |
pMJ7 | pBluescript II KS(+) derivative harboring the promoterless araE coding region, bla | This work |
pMJ10 | Integrative plasmid used for the creation of area-null mutations, bla, kan | This work |
pMJ11 | Integrative plasmid used for the creation of araNPQ in-frame deletion mutants, bla, erm | This work |
B. subtilis strains | ||
168T+ | Prototroph | F. E. Young |
IQB206 | ΔaraL-abfA::spc | 23 |
IQB495 | ΔmsmX::cat | pMJ2a→168T+ |
IQB496 | ΔaraN | pMJ6→168T+ |
IQB608 | araE::kan | pMJ10a→168T+ |
IQB609 | ΔmsmX::cat araE::kan | pMJ10a→IQB495 |
IQB610 | ΔaraN araE::kan | pMJ10a→IQB496 |
IQB611 | ΔaraNPQ | pMJ11→168T+ |
Oligonucleotides | ||
ARA422 | TATTGAGCTCTCAGGGATAGATATCAAATCG | |
ARA423 | CATCGGTACCATTCTGAGATTTTCAATAGC | |
ARA426 | GCGGATCCCTTTGGTGACATGCTCGG | |
ARA427 | CGCTTTCACTTTTTGAATGGGCTGCGTTACCCCTTCCATTCGAGGTGCGGG | |
ARA428 | CCCGCACCTCGAATGGAAGGGGTAACGCAGCCCATTCAAAAAGTGAAAGCG | |
ARA429 | GCTTAGTACTGCTCTTTCGGCACATTTTGC | |
ARA448 | GATAAAGTACTTTTCGAAAAAAGTCATTTTTTTCATCTGCGTTACCCCTTC | |
ARA449 | GAAGGGGTAACGCAGATGAAAAAAATGACTTTTTTCCAAAAGTACTTTATC | |
ARA450 | GGCATGCGCATGTTTGAGCTGCCGCAGGC | |
ARA467 | CCAGCAATATTTTATCC | |
ARA488 | CAAATTTCGGTACCTCACAGCG |
Transformation was carried out with linearized DNA. The restriction sites used are underlined.
The arrows indicate transformation and point from donor DNA to the recipient strain.